EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Perspectives on cutting‐edge nanoparticulate drug delivery technologies based on lipids and their applications

Balaji Maddiboyina, Ramaiah, Ramya Krishna Nakkala, Harekrishna Roy

Chemical Biology & Drug Design · 2023

DOI: 10.1111/cbdd.14230 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Chemical Biology & Drug Design, 2023. Verfasst von Balaji Maddiboyina und 3 weiteren Autor:innen. Beteiligte Einrichtung: Freyr Solutions, Phoenix SEZ, Hyderabad, Telangana, India. Hauptthemen laut MEDLINE: Nanoparticles, Nanostructures. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 142 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Numerous nanotech arenas in therapeutic biology have recently provided a scientific platform to manufacture a considerable swath of unique chemical entities focusing on drugs. Recently, nanoparticulate drug delivery systems have emerged to deliver a specific drug to a specified site. Among all other carriers, lipids possess features exclusive to nanostructured dosage forms. The bioavailability of orally administered drugs is typically negatively affected by their poor water solubility, resulting from the unique chemical moieties introduced. Because of their unique advantages, lipid nanoparticles must become increasingly predictable as a robust delivery mechanism. The enhanced biopharmaceutical properties and significance of lipid‐based targeting technologies such as liposomes, niosomes, solid lipid nanoparticles and micelles are highlighted in this review. Pharmaceutical implications of lipid nanocarriers for the transport and distribution of various therapeutic agents, such as biotechnological products and small pharmaceutical molecules, is a booming topic. Lipid nanoparticles as drug delivery systems have many appealing properties, including high biocompatibility, ease of preparation, tissue specificity, avoidance of reticuloendothelial systems, delayed drug release, scale‐up feasibility, nontoxicity and targeted delivery. The use of lipid nanoparticles to enhance the transport of biopharmaceuticals is currently considered state‐of‐the‐art. Similarly, we critically examine the upcoming guidelines that therapeutic scientists should handle.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesNanostructuresDrug CarriersDrug Delivery SystemsLiposomesMicellesLipids

Stichwörter der Autor:innen

Niosomeslipid nanoparticlesliposomesmicellessolid-lipid nanoparticles

Substanzen

Drug CarriersLiposomesMicellesLipids

Autor:innen und Institutionen

  • Freyr Solutions, Phoenix SEZ, Hyderabad, Telangana, India.
  • Vishwa Bharathi College of Pharmaceutical Sciences, Guntur, Andhra Pradesh, India.
  • Nirmala College of Pharmacy, Guntur, Andhra Pradesh, India.

Zitieren

APA

Maddiboyina, B., Ramaiah, Nakkala, R. K., & Roy, H. (2023). Perspectives on cutting‐edge nanoparticulate drug delivery technologies based on lipids and their applications. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14230

Vancouver

Maddiboyina B, Ramaiah, Nakkala RK, Roy H. Perspectives on cutting‐edge nanoparticulate drug delivery technologies based on lipids and their applications. Chemical Biology & Drug Design. 2023. doi:10.1111/cbdd.14230

BibTeX
@article{Maddiboyina2023,
  author = {Maddiboyina, Balaji and Ramaiah and Nakkala, Ramya Krishna and Roy, Harekrishna},
  title = {Perspectives on cutting‐edge nanoparticulate drug delivery technologies based on lipids and their applications},
  journal = {Chemical Biology & Drug Design},
  year = {2023},
  doi = {10.1111/cbdd.14230}
}
Kostenlos starten →